Immunodeficiency and immune dysregulation associated with proximal defects of T cell receptor signaling

Current Opinion in Immunology

Volumn 31, Issue , 2014, Pages 97-101

  Notarangelo, Luigi D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 INDUCIBLE TYROSINE KINASE; MACROPHAGE STIMULATING 1 PROTEIN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; CD3 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CYTOKINE PRODUCTION; ENZYME DEFICIENCY; GENE MUTATION; GENETIC DISORDER; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; ANIMAL; GENETICS; IMMUNOLOGY; MOUSE; MUTATION; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; AUTOIMMUNE DISEASES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MUTATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84908461154     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.10.003     Document Type: Review

References (54)

1. Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev 2009, 228:9-22.
2. Andreotti A.H., Schwartzberg P.L., Joseph R.E., Berg L.J. T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol 2010, 2:a002287.
3. Elder M.E., Lin D., Clever J., Chan A.C., Hope T.J., Weiss A., Parslow T.G. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 1994, 264:1596-1599.
4. Arpaia E., Shahar M., Dadi H., Cohen A., Roifman C.M. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 1994, 76:947-958.
5. Chan A.C., Kadlecek T.A., Elder M.E., Filipovich A.H., Kuo W.L., Iwashima M., Parslow T.G., Weiss A. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994, 264:1599-1601.
6. Negishi I., Motoyama N., Nakayama K., Nakayama K., Senju S., Hatakeyama S., Zhang Q., Chan A.C., Loh D.Y. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 1995, 376:435-438.
7. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., Sakihama T., Matsutani T., Negishi I., Nakatsuru S., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
8. Sakaguchi S., Benham H., Cope A.P., Thomas R. T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. Immunol Cell Biol 2012, 90:277-287.
9. Siggs O.M., Miosge L.A., Yates A.L., Kucharska E.M., Sheahan D., Brdicka T., Weiss A., Liston A., Goodnow C.C. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 2007, 27:912-926.
10. Katamura K., Tai G., Tachibana T., Yamabe H., Ohmori K., Mayumi M., Matsuda S., Koyasu S., Furusho K. Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency. Clin Exp Immunol 1999, 115:124-130.
11. Turul T., Tezcan I., Artac H., de Bruin-Versteeg S., Barendregt B.H., Reisli I., Sanal O., van Dongen J.J., van der Burg M. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur J Pediatr 2009, 168:87-93.
12. Roifman C.M., Dadi H., Somech R., Nahum A., Sharfe N. Characterization of zeta-associated protein, 70kDa (ZAP70)-deficient human lymphocytes. J Allergy Clin Immunol 2010, 126:1226-1233. e1221.
13. Poliani P.L., Fontana E., Roifman C.M., Notarangelo L.D. zeta Chain-associated protein of 70kDa (ZAP70) deficiency in human subjects is associated with abnormalities of thymic stromal cells: implications for T-cell tolerance. J Allergy Clin Immunol 2013, 131:597-600. e591-592.
14. Hauck F., Randriamampita C., Martin E., Gerart S., Lambert N., Lim A., Soulier J., Maciorowski Z., Touzot F., Moshous D., et al. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin Immunol 2012, 130:1144-1152. e1111.
15. Du X., Shi H., Li J., Dong Y., Liang J., Ye J., Kong S., Zhang S., Zhong T., Yuan Z., et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J Immunol 2014, 192:1525-1535.
16. Kerdiles Y.M., Stone E.L., Beisner D.R., McGargill M.A., Ch'en I.L., Stockmann C., Katayama C.D., Hedrick S.M. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
17. Ouyang W., Beckett O., Ma Q., Paik J.H., DePinho R.A., Li M.O. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 2010, 11:618-627.
18. Huang H., Regan K.M., Wang F., Wang D., Smith D.I., van Deursen J.M., Tindall D.J. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci USA 2005, 102:1649-1654.
19. Ueda Y., Katagiri K., Tomiyama T., Yasuda K., Habiro K., Katakai T., Ikehara S., Matsumoto M., Kinashi T. Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus. Nat Commun 2012, 3:1098.
20. Tomiyama T., Ueda Y., Katakai T., Kondo N., Okazaki K., Kinashi T. Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase. PLoS ONE 2013, 8:e73874.
21. Mou F., Praskova M., Xia F., Van Buren D., Hock H., Avruch J., Zhou D. The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J Exp Med 2012, 209:741-759.
22. Dong Y., Du X., Ye J., Han M., Xu T., Zhuang Y., Tao W. A cell-intrinsic role for Mst1 in regulating thymocyte egress. J Immunol 2009, 183:3865-3872.
23. Salojin K.V., Hamman B.D., Chang W.C., Jhaver K.G., Al-Shami A., Crisostomo J., Wilkins C., Digeorge-Foushee A.M., Allen J., Patel N., et al. Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. PLoS ONE 2014, 9:e98151.
24. Zhou D., Medoff B.D., Chen L., Li L., Zhang X.F., Praskova M., Liu M., Landry A., Blumberg R.S., Boussiotis V.A., et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Proc Natl Acad Sci USA 2008, 105:20321-20326.
25. Katagiri K., Katakai T., Ebisuno Y., Ueda Y., Okada T., Kinashi T. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J 2009, 28:1319-1331.
26. Choi J., Oh S., Lee D., Oh H.J., Park J.Y., Lee S.B., Lim D.S. Mst1-FoxO signaling protects Naive T lymphocytes from cellular oxidative stress in mice. PLoS ONE 2009, 4:e8011.
27. Abdollahpour H., Appaswamy G., Kotlarz D., Diestelhorst J., Beier R., Schaffer A.A., Gertz E.M., Schambach A., Kreipe H.H., Pfeifer D., et al. The phenotype of human STK4 deficiency. Blood 2012, 119:3450-3457.
28. Nehme N.T., Pachlopnik Schmid J., Debeurme F., Andre-Schmutz I., Lim A., Nitschke P., Rieux-Laucat F., Lutz P., Picard C., Mahlaoui N., et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 2012, 119:3458-3468.
29. Liao X.C., Littman D.R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995, 3:757-769.
30. Schaeffer E.M., Broussard C., Debnath J., Anderson S., McVicar D.W., Schwartzberg P.L. Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med 2000, 192:987-1000.
31. Atherly L.O., Lucas J.A., Felices M., Yin C.C., Reiner S.L., Berg L.J. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity 2006, 25:79-91.
32. Broussard C., Fleischacker C., Horai R., Chetana M., Venegas A.M., Sharp L.L., Hedrick S.M., Fowlkes B.J., Schwartzberg P.L. Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. Immunity 2006, 25:93-104.
33. Nayar R., Enos M., Prince A., Shin H., Hemmers S., Jiang J.K., Klein U., Thomas C.J., Berg L.J. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc Natl Acad Sci USA 2012, 109:E2794-E2802.
34. Au-Yeung B.B., Fowell D.J. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J Immunol 2007, 179:111-119.
35. Felices M., Berg L.J. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J Immunol 2008, 180:3007-3018.
36. Qi Q., Huang W., Bai Y., Balmus G., Weiss R.S., August A. A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice. J Immunol 2012, 188:3611-3619.
37. Miller A.T., Berg L.J. Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase. J Immunol 2002, 168:2163-2172.
38. Miller A.T., Wilcox H.M., Lai Z., Berg L.J. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 2004, 21:67-80.
39. Yin C.C., Cho O.H., Sylvia K.E., Narayan K., Prince A.L., Evans J.W., Kang J., Berg L.J. The Tec kinase ITK regulates thymic expansion, emigration, and maturation of gammadelta NKT cells. J Immunol 2013, 190:2659-2669.
40. Gomez-Rodriguez J., Wohlfert E.A., Handon R., Meylan F., Wu J.Z., Anderson S.M., Kirby M.R., Belkaid Y., Schwartzberg P.L. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J Exp Med 2014, 211:529-543.
41. Berg L.J., Finkelstein L.D., Lucas J.A., Schwartzberg P.L. Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 2005, 23:549-600.
42. Huang W., Jeong A.R., Kannan A.K., Huang L., August A. IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function. J Immunol 2014, 193:2267-2272.
43. Huck K., Feyen O., Niehues T., Ruschendorf F., Hubner N., Laws H.J., Telieps T., Knapp S., Wacker H.H., Meindl A., et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 2009, 119:1350-1358.
44. Linka R.M., Risse S.L., Bienemann K., Werner M., Linka Y., Krux F., Synaeve C., Deenen R., Ginzel S., Dvorsky R., et al. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 2012, 26:963-971.
45. Mansouri D., Mahdaviani S.A., Khalilzadeh S., Mohajerani S.A., Hasanzad M., Sadr S., Nadji S.A., Karimi S., Droodinia A., Rezaei N., et al. IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection. Int Arch Allergy Immunol 2012, 158:418-422.
46. Stepensky P., Weintraub M., Yanir A., Revel-Vilk S., Krux F., Huck K., Linka R.M., Shaag A., Elpeleg O., Borkhardt A., et al. IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach. Haematologica 2011, 96:472-476.
47. Caton A.J., Kropf E., Simons D.M., Aitken M., Weissler K.A., Jordan M.S. Strength of TCR signal from self-peptide modulates autoreactive thymocyte deletion and Foxp3(+) Treg-cell formation. Eur J Immunol 2014, 44:785-793.
48. Salek M., McGowan S., Trudgian D.C., Dushek O., de Wet B., Efstathiou G., Acuto O. Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PLoS ONE 2013, 8:e77423.
49. Sommers C.L., Lee J., Steiner K.L., Gurson J.M., Depersis C.L., El-Khoury D., Fuller C.L., Shores E.W., Love P.E., Samelson L.E. Mutation of the phospholipase C-gamma1-binding site of LAT affects both positive and negative thymocyte selection. J Exp Med 2005, 201:1125-1134.
50. Picard C., McCarl C.A., Papolos A., Khalil S., Luthy K., Hivroz C., LeDeist F., Rieux-Laucat F., Rechavi G., Rao A., et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009, 360:1971-1980.
51. Shaw P.J., Feske S. Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity. J Physiol 2012, 590:4157-4167.
52. Janssen E.M.H., Ullas S., Bannock J.M., Massad C., Menard L., Barlan I., Lefranc G., Su H., Dasouki M., Al-Herz W., Keles S., Chatila T., Geha R.S., Meffre E. Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol 2014, [Epub ahead of print].
53. Jain N., Miu B., Jiang J.K., McKinstry K.K., Prince A., Swain S.L., Greiner D.L., Thomas C.J., Sanderson M.J., Berg L.J., et al. CD28 and ITK signals regulate autoreactive T cell trafficking. Nat Med 2013, 19:1632-1637.
54. Vargas L., Hamasy A., Nore B.F., Smith C.I. Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases. Scand J Immunol 2013, 78:130-139.